Clinical trial
Prevalence of Antiphospholipid Antibodies in Ankylosing Spondylitis: A Study of 80 Patients
NCT02809300 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Antiphospholipid Antibodies in Ankylosing Spondylitis: A Study of 80 Patients
- Lead sponsor
- CHU de Reims
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2015
- Completion date
- Not reported
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylarthritis